Effect of low-dose probucol therapy on LDL oxidation and the plasma lipoprotein profile in male volunteers

This publication has 29 references indexed in Scilit:

• AN ANALYSIS OF THE TIME‐RELATIONS OF ELECTROCARDIOGRAMS.
  Annals of Noninvasive Electrocardiology, 1997
• Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
• Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein.
  Journal of Clinical Investigation, 1991
• β-Carotene inhibits the oxidative modification of low-density lipoprotein
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
• Attenuation of atherosclerosis in a modified strain of hypercholesterolemic Watanabe rabbits with use of a probucol analogue (MDL 29,311) that does not lower serum cholesterol.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
• Varying susceptibility of different low density lipoproteins to oxidative modification.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
• Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitro
  Atherosclerosis, 1990
• Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.
  Journal of Clinical Investigation, 1989
• Book ReviewAmbulatory Pediatric Care
  New England Journal of Medicine, 1989
• Effects of probucol on xanthomata regression in familial hypercholesterolemia
  The American Journal of Cardiology, 1986